Journal of Radiology Nursing
Volume 26, Issue 3 , Pages 77-85 , September 2007

Nuclear Medicine Technology: Inflammation and Infection Imaging

  • Christina A. Truluck, PhD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Christina A. Truluck, Thomas Jefferson University, Jefferson College of Health Professions, 130 S. 9th Street, Suite 1009, Philadelphia PA 19107.

References 

  1. Bleeker-Rovers CP, de Kleijn EM, Corstens FH, van der Meer JW, Oyen WJ. Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation. European Journal of Nuclear Medicine and Molecular Imaging. 2004;31:29–37
  2. Britton KE, Wareham DW, Das SS, Solanki KK, Amaral H, Bhatnagar A, et al. Imaging bacterial infection with 99mTc-ciprofloxacin (infection). Journal of Clinical Pathology. 2002;55:817–823
  3. Corstens FH, van der Meer JW. Nuclear medicine's role in infection and inflammation. Lancet. 1999;354:765–770
  4. Datz FL, Seabold JE, Brown ML, Forstrom LA, Greenspan BS, McAfee JG, et al. Procedure guideline for Technetium-99m-HMPAO-labeled leukocyte scintigraphy for suspected infection/inflammation. Journal of Nuclear Medicine. 1997;30:987–990
  5. van Eerd JE, Boerman OC, Corstens FH, Oyen WJ. Radiolabeled chemotactic cytokines: New agents for scintigraphic imaging of infection and inflammation. Quarterly Journal of Nuclear Medicine. 2003;47:246–255
  6. FDA Public Health Advisory: Suspended marketing of NeutroSpec. An online publication from the U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Retrieved from http://www.fda.gov/cder/drug/advisory/technetium99.htmSeptember 2, 2006
  7. Hughes DK. Nuclear medicine and infection detection: The relative effectiveness of imaging with 111In-onine-, 99mTc-HMPAO-, and 99mTc-stannous fluoride colloid-labeled leukocytes and with 67Ga-citrate. Journal of Nuclear Medicine Technology. 2003;31:196–201
  8. Knight LC. Non-oncologic applications of radiolabeled peptides in nuclear medicine. Quarterly Journal of Nuclear Medicine. 2003;47:279–291
  9. Kumar V. Radiolabeled WBCs and direct targeting of microorganisms for infection imaging. Quarterly Journal of Nuclear Medicine and Molecular Imaging. 2005;49:325–338
  10. Love C, Din AB, Tomas MB, Kalapparambath TP, Palestro CJ. Radionuclide bone imaging: An illustrative review. RadioGraphics. 2003;23:341–358
  11. Love C, Palestro CJ. Radionuclide imaging of infection. Journal of Nuclear Medicine Technology. 2004;32:47–57
  12. Love C, Tomas MB, Marwin SE, Pugliese PV, Palestro J. Role of nuclear medicine in diagnosis of infected joint replacement. RadioGraphics. 2001;21:1229–1238
  13. Love C, Tomas MB, Tronco GG, Palestro CJ. FDG PET of infection and inflammation. RadioGraphics. 2005;25:1357–1368
  14. Palestro CJ, Kipper SL, Weiland FL, Love C, Tomas MB. Osteomyelitis: Diagnosis with 99mTc-labeled antigranulocyte antibodies compared with diagnosis with 111In-labeled leukocytes—Initial experience. Radiology. 2002;223:758–764
  15. Palestro CJ, Love C, Tronco GG, Tomas MB. Role of radionuclide imaging in the diagnosis of postoperative infection. RadioGraphics. 2000;20:1649–1660
  16. Peters AM. The use of nuclear medicine in infections. British Journal of Radiology. 1998;71:252–261
  17. Peters AM. Nuclear medicine imaging in fever of unknown origin. Quarterly Journal of Nuclear Medicine. 1999;43:61–73
  18. Rennen HJJM, Boerman OC, Oyen WJG, Corstens FHM. Imaging infection/inflammation in the new millenium. European Journal of Nuclear Medicine. 2001;28:241–252
  19. Rennen HJJM, Boerman OC, Oyen WJG, Corstens FHM. Scintigraphic imaging of inflammatory processes. Current Medicinal Chemistry. 2002;1:63–75
  20. Seabold JE, Forstrom LA, Schauwecker DS, Brown ML, Datz FL, McAfee JG, et al. Procedure guideline for Indium-111-leukocyte scintigraphy for suspected infection/inflammation. Journal of Nuclear Medicine. 1997;38:997–1001
  21. Thakur ML, Marcus CS, Kipper SL, Ahdoot R, Diggles L, Pham HL, et al. Imaging infection with LeuTech®. Nuclear Medicine Communications. 2001;22:513–519
  22. Zhuang H, Alavi A. 18-Fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Seminars in Nuclear Medicine. 2002;32:47–59

PII: S1546-0843(07)00076-4

doi: 10.1016/j.jradnu.2007.04.004

Journal of Radiology Nursing
Volume 26, Issue 3 , Pages 77-85 , September 2007

Article Tools

* Image Usage & Resolution